Evidence map›Paper›PMID 35739327›Full record

ArticleArchives of microbiology2022

Characterization of exopolysaccharide produced by probiotic Enterococcus durans DU1 and evaluation of its anti-biofilm activity.

Omid Soliemani, Fatemeh Salimi, Arezou Rezaei

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Recent advances in the biological activities of microbial exopolysaccharides.World journal of microbiology & biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Omid SoliemaniDepartment of Cellular and Molecular Biology, School of Biology, Damghan University, Damghan, 36716-41167, Iran.
Fatemeh SalimiDepartment of Cellular and Molecular Biology, School of Biology, Damghan University, Damghan, 36716-41167, Iran. f.salimi@du.ac.ir.ORCID http://orcid.org/0000-0002-8771-5337
Arezou RezaeiDepartment of Cellular and Molecular Biology, School of Biology, Damghan University, Damghan, 36716-41167, Iran.
Damghan University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exopolysaccharides (EPS) produced by lactic acid bacteria are complicated polymers with industrial applications. LAB were isolated, screened for EPS production, and their probiotic properties determined. The anti-biofilm activity of EPS was investigated. Safety of EPS-producing isolate was investigated and it was molecularly identified through 16S rRNA sequencing. Finally, anti-biofilm and emulsification activity of EPS was studied and it was characterized using FT-IR, TGA,

Indexed as

Polysaccharides, BacterialProbioticsBiofilmsEnterococcusRNA, Ribosomal, 16SSpectroscopy, Fourier Transform InfraredStaphylococcus aureusPolysaccharides, BacterialRNA, Ribosomal, 16SBiofilm suppressionExopolysaccharideLactic acid bacteriaProbiotic properties

Identifiers

PMID35739327
OpenAlexW4283379658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.